LEHBI Renal Care
LEHBI Logo

Investors & Strategic Partners

A scalable, value-based dialysis platform aligned with Saudi Vision 2030.

📄 Download Investor Deck (PDF)
0
Established
0
Dialysis Beds
0
Patient Satisfaction
0
Patients by 2029

Value-Based Kidney Care

LEHBI’s care model aligns with the Saudi Ministry of Health’s Value-Based Healthcare (VBHC) framework — delivering superior clinical outcomes while optimizing system-wide costs.

Early CKD Management

Early identification and proactive management of chronic kidney disease to slow progression, reduce complications, and delay the need for renal replacement therapy.

Integrated Kidney Care

A coordinated, multidisciplinary approach combining dialysis care, vascular access, nutrition, nursing, and psychosocial support to improve outcomes and reduce fragmentation.

High-Value Dialysis Delivery

Optimized in-center and home dialysis modalities designed to lower hospitalization rates, improve quality of life, and achieve sustainable cost efficiency.

Mortality
Improved long-term survival outcomes
Hospital Admissions
Fewer acute complications & emergencies
Total Cost of Care
Sustainable economics for payers & systems

Operational Quality & Outcomes

Vascular Access Mix (%)

Infection Rate Trend

99.4%
Treatment Adherence
<0.8%
Unplanned Session Cancellations
24/7
Clinical Coverage
100%
MOH Compliance Audits

Quality Performance vs Benchmarks

Bloodstream Infection Rate

LEHBI: 0.6%

Intl. Benchmark: 1.2%

Permanent Access Usage

LEHBI: 77%

Intl. Benchmark: 65%

Hospitalization Rate

LEHBI: ↓ 18%

Peer Average

All clinical outcomes are reviewed monthly by the Clinical Governance Committee, with corrective actions tracked through standardized quality improvement protocols.
Standardized clinical protocols • Centralized governance • Scalable staffing model

Financial & Growth Highlights

A diversified revenue base, disciplined cost structure, and a clearly defined expansion roadmap support sustainable, long-term value creation.

Revenue Drivers

Core revenues are generated through in-center dialysis services, home dialysis therapies, vascular access programs, and long-term contracts with the Ministry of Health.

Cost Efficiency

LEHBI’s operating model emphasizes reduced hospitalizations, optimized workforce utilization, and higher use of permanent vascular access, lowering total cost of care.

Expansion Strategy

A phased regional expansion strategy targeting Central, Western, Southern, and Eastern regions to reach approximately 3,000 patients by 2029.

Investment Thesis: LEHBI combines predictable healthcare demand, strong government alignment, and a scalable delivery model to generate resilient, long-term returns.

Governance, Leadership & Oversight

LEHBI’s governance framework is designed to support clinical excellence, operational discipline, and sustainable long-term value creation.

Dr. Ali Allehbi

Founder & Medical Director

  • Harvard & Tufts University trained nephrologist with American Board certifications in Internal Medicine and Nephrology.
  • Former Chief of Renal Services at King Faisal Specialist Hospital & Research Centre (KFSHRC).
  • Associate Professor at King Faisal University with extensive academic and clinical leadership experience.
  • Author of 30+ peer-reviewed publications and 75+ international scientific presentations.

Board & Advisory Committee

LEHBI is in the process of formalizing a Board of Directors and Advisory Committee to support strategic oversight, growth planning, and institutional governance.

Planned representation includes healthcare operators, financial experts, and independent advisors. (Coming Soon)

Clinical Governance Committee

A dedicated Clinical Governance Committee oversees patient safety, quality standards, infection control, and compliance with Ministry of Health regulations across all centers.

Compliance & Risk Oversight

  • • Adherence to Saudi Ministry of Health and regulatory standards
  • • Continuous monitoring of clinical, operational, and financial risks
  • • Internal audit, infection control audits, and quality assurance programs
  • • Data protection and patient confidentiality governance

Succession Planning

LEHBI is committed to long-term leadership continuity through structured succession planning, development of senior clinical and operational leaders, and reduced dependency on any single individual.

Investor Perspective: Institutional governance, clinical accountability, and leadership continuity are core pillars supporting LEHBI’s scalability and investment readiness.

Clinical KPIs Oversight

Infection Rate

Below benchmark

Hospital Admissions

Reduced frequency

Dialysis Adequacy

Protocol compliant

Patient Satisfaction

Consistently >95%

KPIs are reviewed regularly by the Clinical Governance Committee to ensure alignment with Ministry of Health standards and international best practices.

Risk Oversight Heatmap

Clinical Risk
Low
Operational Risk
Moderate
Regulatory Risk
Low
Workforce Risk
Moderate
Financial Risk
Low
Expansion Risk
Moderate

Risks are actively monitored through governance, compliance audits, and phased expansion controls.

ESG & Sustainability Committee

LEHBI integrates Environmental, Social, and Governance (ESG) principles into its operating model to support long-term sustainability, workforce well-being, and responsible healthcare delivery.

Environmental

Efficient resource utilization, waste management, and responsible dialysis operations.

Social

Patient-centered care, workforce development, and community engagement.

Governance

Ethical leadership, regulatory compliance, and transparent decision-making.

Strategic Roadmap & 2030 Expansion Plan

LEHBI’s roadmap is designed to scale access to high-quality dialysis care across the Kingdom while maintaining clinical excellence, operational discipline, and alignment with Vision 2030.

Phase I — Foundation & Optimization

Current Phase

Strengthening existing operations in Riyadh through quality optimization, infection control leadership, and expansion of home dialysis and integrated kidney care programs.

  • • Highest infection control audit performance
  • • Expansion of home hemodialysis programs
  • • Early CKD management and VBHC alignment

Phase II — Regional Expansion

Mid-Term Growth

Geographic expansion beyond Riyadh to increase national coverage, supported by standardized clinical protocols and centralized governance.

  • • Central Region: ~12.22% patient coverage
  • • Western Region: ~12.08% patient coverage
  • • Southern Region: ~10.02% patient coverage
  • • Northern Region: ~6.09% patient coverage
  • • Eastern Region: ~6.03% patient coverage

Phase III — Scale & National Impact

By 2029–2030

Achieving national scale through disciplined rollout, partnerships, and integration with government and payer systems.

  • • Target of approximately 3,000 patients by 2029
  • • Contribution to private sector growth and GDP
  • • Positioning KSA as a regional medical tourism destination

Vision 2030 Alignment: LEHBI’s roadmap directly supports Saudi Arabia’s Vision 2030 objectives by strengthening local healthcare providers, enabling SME growth, and advancing the Kingdom’s global healthcare reputation.

Partner With LEHBI

A proven platform. A national healthcare priority. A scalable investment opportunity.

Contact Investor Relations
WhatsApp